El INMEGEN cuenta con una unidad de información especializada en medicina genómica y áreas afines, el Centro de Información y Documentación (CID). El CID tiene un acervo que abarca temas de Bioinformática, biología celular y molecular, biotecnología, cáncer, diabetes, enfermedades cardiovasculares e infecciosas, estudios éticos, legales y sociales, farmacogenómica, genómica poblacional, nutrigenómica, entre otros.
Para conocer más acerca de los servicios que ofrece el CID visite: http://www.inmegen.gob.mx/es/biblioteca/
| Recomendaciones de la Biblioteca - Artículos de Alta Especialidad |
New England Journal of Medicine – Getting to the Heart of Proteomics – January 29, 2009
Chen and colleagues recently described mitochondrial aldehyde dehydrogenase type 2 (ALDH2) as a target in protecting the heart against ischemic insult. Their study provides insights into cardiovascular biology and may form the basis of a potential therapeutic approach to prevent or minimize myocardial ischemic injury in the clinical setting.
|
| |
Recommendations from the 2008 International Summit on Proteomics Data Release and Sharing Policy: the Amsterdam principles
Policies supporting the rapid and open sharing of genomic data have directly fueled the accelerated pace of discovery in large-scale genomics research. The proteomics community is starting to implement analogous policies and infrastructure for making 2008, the National Cancer Institute (NCI) convened the "International Summit on Proteomics Data Release and Sharing Policy" in Amsterdam, The Netherlands, to identify and address potential roadblocks to rapid and open access to data. The six principles agreed upon by key stakeholders at the summit addressed issues surrounding (1) timing, (2) comprehensiveness, (3) format, (4) deposition to repositories, (5) quality metrics, and (6) responsibility for proteomics data release. This summit report explores various approaches to develop a framework of data release and sharing principles that will most effectively fulfill the needs of the funding agencies and the research community. |
| |
The human proteome - a scientific opportunity for transforming diagnostics, therapeutics, and healthcare
A National Institutes of Health (NIH) workshop was convened in Bethesda, MD on September 26-27, 2011, with representative scientific leaders in the field of proteomics and its applications to clinical settings. The main purpose of this workshop was to articulate ways in which the biomedical research community can capitalize on recent technology advances and synergize with ongoing efforts to advance the field of human proteomics. This executive summary and the following full report describe the main discussions and outcomes of the workshop.
|
| |
Para consultar publicaciones científicas de los investigadores del INMEGEN visite: http://www.inmegen.gob.mx/es/investigacion/publicaciones-cientificas
|
